Description

BSE revokes the suspension of trading in equity shares of Citurgia Biochemicals Limited (Scrip Code: 506373), allowing trading to resume.

Summary

BSE has revoked the suspension of trading in equity shares of Citurgia Biochemicals Limited (Scrip Code: 506373, ISIN: INE795B01031). The company can now resume trading on the exchange. The circular includes a comprehensive company profile as part of Annexure IV.

Key Points

  • Trading suspension has been revoked for Citurgia Biochemicals Limited
  • Scrip Code: 506373
  • ISIN: INE795B01031
  • Company is a manufacturer, producer, processor, refiner, exporter and importer of citric acid
  • Registered Office: Office No. 427, A-Wing, 4th Floor, Mainframe Premises C.S.L Royal Palms, Goregaon East, Mumbai-400065
  • Plant Location: Virbhadra Road, Rishikesh, Uttarakhand – 249201
  • Listed only on BSE Limited
  • Operational Status: Active
  • Company is in the process of appointing a Company Secretary & Compliance Officer

Company Details

Board of Directors:

  • Mr. Vivek Singh (9718850902)
  • Ms. Reena Devi Mandal (8826806397)
  • Mr. Subhash Sahu (9039089848)
  • Mr. Kashi Nath Jha - Whole Time Director (DIN: 02072952, 9891019533)
  • Mr. Dharmendra (8800483191)
  • Mr. Jitendra Prasad (9893295600)

Auditor: G.P. Keshri & Associates (Appointed for FY 01.04.2022 to 31.03.2027)

Contact: citurgia_bio@yahoo.com, www.citurgiabiochemicals.com

Regulatory Changes

The revocation of suspension removes previous trading restrictions on the company’s equity shares, allowing normal trading activities to resume.

Compliance Requirements

  • Company has paid listing fees to BSE
  • No group companies reported
  • No action taken by other exchanges in the last five years
  • No name change in the last five years
  • No change in main line of business in the last five years

Important Dates

  • Company Profile Date: 07.11.2025
  • Circular Date: 2026-01-30

Impact Assessment

The revocation allows shareholders and investors to resume trading in Citurgia Biochemicals’ equity shares on BSE. This restores liquidity for existing shareholders and enables new investors to participate. The company’s active operational status in citric acid manufacturing indicates ongoing business operations during the suspension period.

Impact Justification

Revocation of trading suspension affects shareholders and investors in Citurgia Biochemicals, allowing them to trade shares again. Company profile indicates active operational status.